Physician profile
Christopher Francis
NPI 1740771252
$570.42
in general payments reported to CMS, 2019-2025
14 companies · $56.06 in 2025
The $56.06 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35.09 · 2023: $321 · 2024: $158 · 2025: $56.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $535.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $535.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $134.15 | 2019-2024 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $66.14 | 2023 | |
| Exact Sciences Corporation | $55.66 | 2023 | Cologuard Collection Kit |
| Lilly USA, LLC | $47.66 | 2024 | Zepbound, Jardiance, Mounjaro |
| Glaxosmithkline, LLC. | $38.63 | 2019-2023 | Shingrix |
| Lucid Diagnostics INC. | $33.35 | 2023 | |
| Hologic Sales and Service, LLC | $33.04 | 2024 | Thinprep 2000 Processor |
| Astellas Pharma US INC | $32.90 | 2023 | Veozah |
| Abbott Laboratories | $31.46 | 2025 | Freestyle Libre 3 |
| Shockwave Medical, INC | $24.60 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $20.45 | 2023 | Breztri |
| Cvrx, INC. | $20.03 | 2024 | Barostim Neo System |
| Nestle Healthcare Nutrition INC. | $17.47 | 2023 | |
| Amgen INC. | $14.88 | 2023 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Francis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.